Medicare billing address
CMS Medicare provider billing file
2000 Oxford DrSuite 113
Bethel Park, PA 15102
CMS public data · NPI 1770565095
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
David Helfrich, MD
Specialty
Credential
MD
NPI
1770565095
Primary source state
PA
Data retrieval date
July 28, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for David Helfrich, MD from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
2000 Oxford DrCMS Doctors & Clinicians file
1400 Locust StCMS Doctors & Clinicians file
1400 Locust StCMS Doctors & Clinicians file
2 Hot Metal StIn the 2024 CMS provider billing file, this NPI had 457 Medicare beneficiaries and 172,694 total services. The average beneficiary age was 73, and the average HCC risk score was 1.2.
Total Medicare allowed amount
$1,233,216.11
Total Medicare payment amount
$969,588.69
Medicare beneficiaries
457
Total services
172,694
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hyperlipidemia
74%
CMS beneficiary-panel share
Hypertension
71%
CMS beneficiary-panel share
Osteoporosis
30%
CMS beneficiary-panel share
Anxiety
28%
CMS beneficiary-panel share
Diabetes
23%
CMS beneficiary-panel share
Mood disorders
22%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 124,800 | $4.57 |
| Injection, methylprednisolone acetate, 1 mg | 5,380 | $0.13 |
| Injection, denosumab, 1 mg | 1,110 | $25.37 |
| Injection of drug or substance under skin or into muscle | 746 | $13.43 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 428 | $121.35 |
| Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 215 | $85.79 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 180 | $57.45 |
| Injection, zoledronic acid, 1 mg | 175 | $6.51 |
| Aspiration and/or injection of fluid from large joint | 104 | $71.97 |
| Administration of chemotherapy into vein, 1 hour or less | 95 | $118.31 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1770565095. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Prednisone | Prednisone | 921 | 1,660.2 | $6,445.25 |
| 2 | Methotrexate | Methotrexate Sodium | 726 | 1,416.8 | $19,573.33 |
| 3 | Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 405 | 932.9 | $21,173.35 |
| 4 | Leflunomide | Leflunomide | 198 | 389.5 | $10,123.58 |
| 5 | Gabapentin | Gabapentin | 184 | 342 | $2,255.39 |
| 6 | Meloxicam | Meloxicam | 177 | 354.8 | $603.48 |
| 7 | Alendronate Sodium | Alendronate Sodium | 170 | 441.7 | $1,350.02 |
| 8 | Celecoxib | Celecoxib | 162 | 317.8 | $3,927.80 |
| 9 | Enbrel Sureclick | Etanercept | 156 | 157.8 | $1,257,132.86 |
| 10 | Methylprednisolone | Methylprednisolone | 138 | 158 | $1,987.65 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Medical school
University Of Pittsburgh School Of Medicine
Graduation year
1983
Group/practice field
University Of Pittsburgh Physicians
Telehealth reported
Yes
Secondary specialty fields reported by CMS: Internal Medicine.
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.